GET THE APP

Patient Responsiveness to Cardiovascular Drug Therapies | 25787

International Journal of Pharmacy Teaching & Practices

ISSN - 1986-8111

Abstract

Patient Responsiveness to Cardiovascular Drug Therapies

Ayu Dwi Utami, Syed Wasif Gillani, Muslim Suardi

Background: Cardiovascular Disease or Coronary Heart Disease (CHD) is currently one of the leading causes of death in developed and developing countries. CHD is the heart and blood vessel disease caused by narrowing of the coronary arteries. Narrowing of the arteries due to atherosclerosis process. The main therapy is the administration of antiplatelet, antithrombin, antihyperlipidemia, antihypertensive. Standard in order to take place in an optimal treatment of CHD, it is necessary to constantly monitor the system and monitor the patient receiving drug therapy. Therefore it is necessary for the monitoring of drug therapy in general and in particular the influence of creatinine clearance decline in geriatric patients suffering from CHD. To assess patient response to therapy cardiovascular and clinical outcomes of patients. Study was conducted by the method of longitudinal prospective 4-week cardiology patients. All data obtained from the patient's medical record. Patients were followed up every day and see the clinical outcomes of patients when patients go home from the hospital. Statistic analysis performed using non-parametric test. During the study period found 40 people patients with a diagnosis of which 27 were patients diagnosed with Acute Coroner syndrome (67.5%), and 8 patients were diagnosed with Congestive cardiac failure (20%), and 3 patients with Unstable Angina (7, 5%), and 1 patient with Ischemic Heart Diseases (2.5%), and 1 patient with Non-ST Elevation Myocardial Infarction (2.5%). Generally comes from the Malay race 35 patients (87.5%) and Chinese race 5 patients (12.5%). Of the total patients with a history of smoking are generally 31 patients were smokers (77.5%) and 9 patients were not smokers (22.5%). Found the average age was 59.53 ± 12.675. Length of stay of patients on average 4.15 ± 1.231. Provided that antiplatelet therapy, antithrombin, antihyperlipidemia, antihypertensive. Statistically, no association between the sociodemographic diseases (P> 0.05). Drug therapy given to cardiology patients is appropriate. Where the patients showed good response to therapy, can be seen from the disappearance of clinical symptoms of patients. Clinical outcome improves in the patient upon receiving effective treatment .

 
Top